{"id":"W4387130385","doi":"10.1038/s41591-023-02561-8","title":"Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"National Center for Advancing Translational Sciences; Georgia Clinical and Translational Science Alliance; Ipsen; Regeneron Pharmaceuticals; Vanderbilt University; University of Pennsylvania; Vanderbilt University Medical Center","keywords":"Fibrodysplasia ossificans progressiva; Double blind; Medicine; Placebo; Randomized controlled trial; Internal medicine; Surgery; Heterotopic ossification; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001705036,0.00034419,0.001682964,0.001022066,0.00013617,0.00002489681,0.0001904207,0.0008520195,0.001179976],"category_scores_gemma":[0.001763045,0.0002119762,0.0003245868,0.001527269,0.0004379247,0.00007805583,0.00002677826,0.001851549,0.0001914065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001062912,"about_ca_system_score_gemma":0.0002867411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001898801,"about_ca_topic_score_gemma":0.00001256041,"domain_scores_codex":[0.9967719,0.0002781136,0.001120046,0.0005524291,0.0007668711,0.0005106907],"domain_scores_gemma":[0.9978895,0.0007420261,0.0002807036,0.0005612273,0.0001847711,0.0003418298],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9848828,0.0004967907,0.00003624698,0.00008066898,0.0003280266,0.0004135578,0.0008121696,0.000003092462,0.000933084,0.001751065,0.008057102,0.002205358],"study_design_scores_gemma":[0.9826183,0.0007486801,0.00007603664,0.000578701,0.0005434686,0.00007912072,0.0003203555,0.001346523,0.0003179276,0.0001989253,0.01298054,0.0001914569],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8844008,0.001831162,0.0001020034,0.06080899,0.002817569,0.01836295,0.00001903701,0.0006787942,0.03097874],"genre_scores_gemma":[0.9819768,0.0002401856,0.00006361485,0.0008632293,0.001514841,0.002935312,0.0006189753,0.00004400053,0.01174303],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09757605,"threshold_uncertainty_score":0.9997331,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03778756913034265,"score_gpt":0.3917778725754334,"score_spread":0.3539903034450907,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}